Cambridge Investment Research Advisors’s FT Vest U.S. Equity Max Buffer ETF - October OCTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Sell
22,057
-2,440
-10% -$81.3K ﹤0.01% 2581
2026
Q1
$797K Sell
24,497
-5,298
-18% -$173K ﹤0.01% 2366
2025
Q4
$973K Sell
29,795
-13,734
-32% -$445K ﹤0.01% 2117
2025
Q3
$1.4M Buy
43,529
+246
+0.6% +$7.83K ﹤0.01% 1785
2025
Q2
$1.36M Buy
43,283
+19,368
+81% +$594K ﹤0.01% 1714
2025
Q1
$726K Sell
23,915
-16,513
-41% -$506K ﹤0.01% 2124
2024
Q4
$1.23M Buy
+40,428
New +$1.23M ﹤0.01% 1701

Other funds holding OCTM

Cambridge Investment Research Advisors's OCTM Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its FT Vest U.S. Equity Max Buffer ETF - October (OCTM) stake by 10% in Q2 2026, selling an estimated $81.3K and leaving 22,057 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #2581.

Cambridge Investment Research Advisors first reported a position in OCTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.4M in Q3 2025. 20 funds tracked by Wall St. Rank hold OCTM as of Q2 2026.

  • Cambridge Investment Research Advisors held 22,057 shares of FT Vest U.S. Equity Max Buffer ETF - October worth $741K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,440 FT Vest U.S. Equity Max Buffer ETF - October shares in Q2 2026, an estimated $81.3K.
  • FT Vest U.S. Equity Max Buffer ETF - October made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2581 holding.
  • Cambridge Investment Research Advisors first reported a position in FT Vest U.S. Equity Max Buffer ETF - October in Q4 2024 and has held it in 7 quarters since.
  • Cambridge Investment Research Advisors's FT Vest U.S. Equity Max Buffer ETF - October position peaked at $1.4M in Q3 2025.
  • 20 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - October as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.